Abstract
The incidence and prevalence of chronic dialysis patients in Japan is increasing linearly and is currently as high as 300 and 2300 per million population, respectively. The incidence of end-stage renal disease is closely related to that of chronic dialysis; findings which are captured in detail in the Japanese Society for Dialysis Therapy registry. Life expectancy of dialysis patients is poor compared to the age- and sex-matched general population, and is equivalent to that of an 80-year-old man or an 87-year-old woman, i.e., dialysis patients seem 15–18 years older than their actual age. Cardiac death is the leading cause of death; however, death due to stroke and acute myocardial infarction is decreasing. The annual mortality rate is 6.5% among the dialysis population. For the past 10 years, the mortality risk has remained high despite the avoidance of blood transfusions by the administration of erythropoiesis-stimulating agents, the use of renin−angiotensin system inhibitors, and improvements in general medical care. Several studies have confirmed the significance of chronic kidney disease (CKD) on the development of cardiovascular disease (CVD) and mortality; the lower the estimated glomerular filtration rate (eGFR), the higher the incidence of CVD. The cut-off levels for eGFR are not yet clear. CKD is an important predictor of CVD in Japan, similar to other parts of the world. Strategies for early detection of CKD are needed because, in many cases, CKD remains asymptomatic until late stages. Timely treatment for CKD is necessary to minimize costs for unnecessary care and testing. Unless CDK is properly managed, it will not be possible to maintain quality and longevity of life. The Japanese population is rapidly aging and will have the largest proportion of elderly people in the world. A systematic strategy for managing CKD patients is warranted.
Similar content being viewed by others
References
Nakai S, Masakane I, Shigematsu T, et al. An overview of regular dialysis treatment in Japan (as of December 2007). Ther Apher Dial. 2009;13:457–504.
Imai E, Yamagata K, Iseki K, et al. Kidney disease screening program in Japan, outcome and perspectives. Clin J Am Soc Nephrol. 2007;2:1360–6.
Iseki K, Iseki C, Ikemiya Y, et al. Risk of developing end-stage renal disease in a cohort of mass screening. Kidney Int. 1996;49:800–5.
Parker III T, Hakim R, Nissenson AR, et al. Dialysis at a crossroads: 50 years later. Clin J Am Soc Nephrol. 2011 (Epub Dec 9, 2010).
Kawaguchi Y, Nihei H, Y Hirasawa, et al. Research on establishing guideline for dialysis initiation. In: Mimura S, editor. The Bulletin of 1991 Annual Report of the Kosei-Science Research: project on kidney failure treatment. 1992 p. 125–37.
Iseki K, Shoji T, Nakai S, et al. Higher survival rates of chronic hemodialysis patients on antihypertensive drugs. Nephron Clin Pract. 2009;113:C183–90.
Kramer HJ, Saranathan A, Luke A, et al. Increasing body mass index and obesity in the incident ESRD population. J Am Soc Nephrol. 2006;17:1453–9.
Iseki K, Tohyama K, Matsumoto T, Nakamura H. High prevalence of chronic kidney disease among patients with sleep-related breathing disorder (SRBD). Hypertens Res. 2008;31:249–55.
Iseki K, Shinzato T, Nagura Y, Akiba T. Factors influencing long-term survival in patients on chronic dialysis. Clin Exp Nephrol. 2004;8:89–97.
Nakayama M, Sato T, Sato H, et al. Different clinical outcomes for cardiovascular events and morality in chronic kidney disease according to underlying renal disease: the Gonryo study. Clin Exp Nephrol. 2010;14:333–9.
Yamagata K, Makino H, Akizawa T, et al. Design and methods of a strategic outcome study for chronic kidney disease—Frontier of Renal Outcome Modifications in Japan (FROM-J). Clin Exp Nephrol. 2010;14:144–51.
Guidelines: Evidence-based practice guideline for the treatment of CKD. Exp Nephrol. 2009;13:537–66.
Imai E, Horio M, Nitta K, et al. Estimation of glomerular filtration rate by the MDRD equation modified for Japanese patients with chronic kidney disease. Clin Exp Nephrol. 2007;11:41–50.
Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982–92.
Imai E, Horio M, Iseki K, et al. Prevalence of chronic kidney disease (CKD) in Japanese general population predicted by MDRD equation modified by a Japanese coefficient. Clin Exp Nephrol. 2007;11:156–63.
Iseki K, Horio M, Imai E, Matsuo S, Yamagata K. Geographic difference in prevalence of chronic kidney disease among Japanese screened subjects: Ibaraki vs Okinawa. Clin Exp Nephrol. 2009;13:44–9.
Hallan S, Coresh J, Astor B, et al. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol. 2006;17:2275–84.
Perkovic V, Cass A, Patel AA, et al. High prevalence of chronic kidney disease in Thailand. Kidney Int. 2008;73:473–9.
Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. J Am Med Assoc. 2007;298:2038–47.
Vikse BE, Irgens LM, Leivestad T, et al. Low birth weight increases risk for end-stage renal disease. J Am Soc Nephrol. 2008;19:151–7.
Ritz E. Is the renal risk of adults determined in utero? Kidney Int. 2007;72:667–8.
The Chronic Kidney Disease Prognosis Consortium. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375:2073–81.
Levey AS, de Jong PE, Coresh J, Nahas MF, Astor BC, Matsushita K, et al. The definition, classification and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int (Epub Dec 8, 2010).
Iseki K, Ikemiya Y, Inoue T, et al. Significance of hyperuricemia as a risk factor of developing ESRD in a screened cohort. Am J Kidney Dis. 2004;44:642–50.
Ninomiya T, Kiyohara Y, Kubo M, et al. Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study. Kidney Int. 2005;68:228–36.
Irie F, Iso H, Sairenchi T, et al. The relationships of proteinuria, serum creatinine, glomerular filtration rate with cardiovascular disease mortality in Japanese general population. Kidney Int. 2006;69:1264–71.
The Economist. The future of Japan. 2010; 18 November 20–26.
Acknowledgments
Part of this manuscript was presented at the KDIGO Controversies Conference, October 2010, in London. No financial support was obtained from any institution or company.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Iseki, K. Role of chronic kidney disease in cardiovascular disease: are we different from others?. Clin Exp Nephrol 15, 450–455 (2011). https://doi.org/10.1007/s10157-011-0439-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10157-011-0439-8